Zomedica (ZOMDF) Cash & Equivalents (2016 - 2026)
Zomedica's Cash & Equivalents came in at $7.19 million for Q2 2026, down 11.5% from $8.13 million a year earlier and down 23.2% from the prior quarter.
Powered by 
Analysis
Zomedica (ZOMDF) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, Zomedica's Cash & Equivalents was $9.02 million, up 28.4% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -32.0% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $7.02 million in FY2024 (-45.8%), $12.95 million in FY2023 (-52.7%), $27.4 million in FY2022 (-85.9%) and $194.95 million in FY2021 (+214.5%).
- The Q2 2026 figure represents the lowest quarterly Cash & Equivalents since Q4 2024.
- Year-over-year, Cash & Equivalents increased in three of the last eight quarters, with an average decline of 14.8%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2021 (growth of 421.6%), and the weakest in Q1 2023 (a decline of 95.7%).
- Business Quant data shows ZOMDF's Cash & Equivalents at $9.37 million (Q1 2026), $9.02 million (Q4 2025) and $7.5 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Zomedica | 78.40 Mn | -119.63 Mn | 6.04 Mn | 7.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.19 Mn |
| Mar 31, 2026 | 9.37 Mn |
| Dec 31, 2025 | 9.02 Mn |
| Sep 30, 2025 | 7.50 Mn |
| Jun 30, 2025 | 8.13 Mn |
| Mar 31, 2025 | 8.84 Mn |
| Dec 31, 2024 | 7.02 Mn |
| Sep 30, 2024 | 9.75 Mn |
| Jun 30, 2024 | 7.94 Mn |
| Mar 31, 2024 | 10.94 Mn |
| Dec 31, 2023 | 12.95 Mn |
| Sep 30, 2023 | 21.78 Mn |
| Jun 30, 2023 | 27.95 Mn |
| Mar 31, 2023 | 8.35 Mn |
| Dec 31, 2022 | 27.40 Mn |
| Sep 30, 2022 | 45.10 Mn |
| Jun 30, 2022 | 186.76 Mn |
| Mar 31, 2022 | 192.34 Mn |
| Dec 31, 2021 | 194.95 Mn |
| Sep 30, 2021 | 271.41 Mn |
API Access
Zomedica Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ZOMDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ZOMDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();